The Union Health Ministry on Friday revised the prescribed dosage of anti-viral drug Remdesivir for coronavirus patients from six days to five.
According to the updated version of its Clinical Management Protocol for the coronavirus released by the Ministry, the patients must be injected with 200 milligram of Remdesivir on day one and 100 milligram for the next four days.
The Ministry had on June 13 allowed the use of remdesivir for “restricted emergency use” in moderate coronavirus cases.
Hyderabad-based drugmaker Hetero has the approval to manufacture remdesivir for the treatment of coronavirus patients.
Last month, the company had said that it will deliver the first set of the medicine to Maharashtra, Delhi, Tamil Nadu, Gujarat ata price of Rs 5,400 per vial.